Completed OBSERVATIONAL NCT02111590

Immunoglobulin Dosage and Administration Form in CIDP and MMN

The Influence of Immunoglobulin Dosage and Administration on Development of Hemolytic Anemia and Variation on Muscle Strength in Patients With CIDP and MMN

Sponsor: Aarhus University Hospital

Conditions Chronic Inflammatory Demyelinating Polyneuropathy Hemolytic Anemia Multifocal Motor Neuropathy

Interventions Immunoglobulins

Updated 6 times since 2017 Last updated: Sep 18, 2015 Started: Jan 31, 2014 Primary completion: Jul 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Chronic Inflammatory Demyelinating Polyneuropathy and Hemolytic Anemia, this trial is completed. The trial is conducted by Aarhus University Hospital and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aarhus University Hospital
Octapharma Pharmazeutika Produktionsges.m.b.H.
Rigshospitalet, Denmark

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark